Valuation Update With 7 Day Price Move • Jun 01
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to Mex$25.55, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 11x in the Chemicals industry in South America. Total returns to shareholders of 45% over the past three years. Major Estimate Revision • May 02
Consensus EPS estimates increase by 92%, revenue downgraded The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from Mex$17.4b to Mex$16.7b. EPS estimate rose from Mex$1.20 to Mex$2.30. Net income forecast to grow 105% next year vs 34% growth forecast for Chemicals industry in Mexico. Consensus price target up from Mex$52.83 to Mex$54.83. Share price rose 9.5% to Mex$30.00 over the past week. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to Mex$27.10, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 19x in the Chemicals industry in South America. Total returns to shareholders of 71% over the past three years. Declared Dividend • Mar 30
Dividend increased to Mex$0.66 Dividend of Mex$0.66 is 0.4% higher than last year. Ex-date: 7th April 2026 Payment date: 8th April 2026 Dividend yield will be 3.3%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (163% earnings payout ratio). However, it is well covered by cash flows (17% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 81% to bring the payout ratio under control. EPS is expected to grow by 69% over the next 2 years, which means the dividend may need to be reduced to reach a sustainable payout ratio. Ankündigung • Mar 09
Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 25, 2026 Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 25, 2026. Location: ave ricardo margain zozaya, number 335 equus building, tower 2 floor 25, valle del campestre neighborhood, san pedro garza garcia, nuevo leon, mexico Mexico New Risk • Mar 02
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 1.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.2x net interest cover). Minor Risk Dividend is not well covered by earnings (163% payout ratio). Reported Earnings • Mar 02
Full year 2025 earnings released: EPS: Mex$1.00 (vs Mex$1.00 in FY 2024) Full year 2025 results: EPS: Mex$1.00. Revenue: Mex$16.3b (up 8.4% from FY 2024). Net income: Mex$532.7m (down 1.0% from FY 2024). Profit margin: 3.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in South America. Price Target Changed • Mar 01
Price target decreased by 8.9% to Mex$52.83 Down from Mex$58.00, the current price target is an average from 3 analysts. New target price is 172% above last closing price of Mex$19.40. Stock is up 9.1% over the past year. The company posted earnings per share of Mex$1.00 last year. New Risk • Oct 27
New minor risk - Financial position The company has a high level of debt. Net debt to equity ratio: 88% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (88% net debt to equity). Dividend is not well covered by earnings (163% payout ratio). Share price has been volatile over the past 3 months (5.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin). Reported Earnings • Oct 23
Third quarter 2025 earnings released: EPS: Mex$0.27 (vs Mex$0.27 in 3Q 2024) Third quarter 2025 results: EPS: Mex$0.27 (in line with 3Q 2024). Revenue: Mex$4.21b (up 7.2% from 3Q 2024). Net income: Mex$145.7m (flat on 3Q 2024). Profit margin: 3.5% (down from 3.7% in 3Q 2024). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. New Risk • Jul 26
New minor risk - Financial position The company has a high level of debt. Net debt to equity ratio: 89% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (89% net debt to equity). Dividend is not well covered by earnings (152% payout ratio). Profit margins are more than 30% lower than last year (1.3% net profit margin). Reported Earnings • Jul 25
Second quarter 2025 earnings released: EPS: Mex$0.12 (vs Mex$0.52 in 2Q 2024) Second quarter 2025 results: EPS: Mex$0.12 (down from Mex$0.52 in 2Q 2024). Revenue: Mex$4.24b (up 11% from 2Q 2024). Net income: Mex$41.1m (down 85% from 2Q 2024). Profit margin: 1.0% (down from 7.2% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Price Target Changed • Jul 15
Price target increased by 12% to Mex$56.50 Up from Mex$50.50, the current price target is an average from 2 analysts. New target price is 206% above last closing price of Mex$18.46. Stock is up 5.5% over the past year. The company posted earnings per share of Mex$1.00 last year. Declared Dividend • Apr 01
Dividend increased to Mex$0.66 Dividend of Mex$0.66 is 19% higher than last year. Ex-date: 4th April 2025 Payment date: 7th April 2025 Dividend yield will be 3.8%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 3.6% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 71% to shift the payout ratio to a potentially unsustainable range, which is more than the 13% EPS decline seen over the last 5 years. Declared Dividend • Mar 29
Dividend increased to Mex$0.66 Dividend of Mex$0.66 is 19% higher than last year. Ex-date: 4th April 2025 Payment date: 7th April 2025 Dividend yield will be 3.7%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 3.6% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 71% to shift the payout ratio to a potentially unsustainable range, which is more than the 13% EPS decline seen over the last 5 years. Ankündigung • Mar 28
Cydsa, S.A.B. de C.V. announces Annual dividend, payable on April 07, 2025 Cydsa, S.A.B. de C.V. announced Annual dividend of MXN 0.6587 per share payable on April 07, 2025, ex-date on April 04, 2025 and record date on April 04, 2025. New Risk • Mar 07
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (3.6% net profit margin). Ankündigung • Mar 07
Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 26, 2025 Cydsa, S.A.B. de C.V., Annual General Meeting, Mar 26, 2025. Location: ave ricardo margain zozaya, number 335 equus building, tower 2 floor 25, valle del campestre neighborhood, san pedro garza garcia, nuevo leon, mexico Mexico Reported Earnings • Feb 28
Full year 2024 earnings released Full year 2024 results: Revenue: Mex$15.0b (up 6.2% from FY 2023). Net income: Mex$538.4m (down 74% from FY 2023). Profit margin: 3.6% (down from 15% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. New Risk • Oct 25
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.4x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.4x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (7.6% net profit margin). Reported Earnings • Oct 24
Third quarter 2024 earnings released: EPS: Mex$0.27 (vs Mex$1.06 in 3Q 2023) Third quarter 2024 results: EPS: Mex$0.27 (down from Mex$1.06 in 3Q 2023). Revenue: Mex$3.92b (up 16% from 3Q 2023). Net income: Mex$146.2m (down 75% from 3Q 2023). Profit margin: 3.7% (down from 17% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. New Risk • Jul 27
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 17% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Jul 24
Second quarter 2024 earnings released: EPS: Mex$0.52 (vs Mex$1.00 in 2Q 2023) Second quarter 2024 results: EPS: Mex$0.52 (down from Mex$1.00 in 2Q 2023). Revenue: Mex$3.83b (up 15% from 2Q 2023). Net income: Mex$276.6m (down 50% from 2Q 2023). Profit margin: 7.2% (down from 17% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. New Risk • Apr 28
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 18% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (18% operating cash flow to total debt). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Apr 25
First quarter 2024 earnings released: EPS: Mex$0.39 (vs Mex$0.85 in 1Q 2023) First quarter 2024 results: EPS: Mex$0.39 (down from Mex$0.85 in 1Q 2023). Revenue: Mex$3.13b (down 15% from 1Q 2023). Net income: Mex$212.6m (down 54% from 1Q 2023). Profit margin: 6.8% (down from 13% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Reported Earnings • Feb 23
Full year 2023 earnings released: EPS: Mex$3.83 (vs Mex$2.24 in FY 2022) Full year 2023 results: EPS: Mex$3.83 (up from Mex$2.24 in FY 2022). Revenue: Mex$14.2b (up 4.0% from FY 2022). Net income: Mex$2.07b (up 70% from FY 2022). Profit margin: 15% (up from 9.0% in FY 2022). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Global Chemicals industry. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. New Risk • Oct 27
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 20% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Oct 26
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: Mex$3.38b (down 4.9% from 3Q 2022). Net income: Mex$581.2m (up 161% from 3Q 2022). Profit margin: 17% (up from 6.3% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in South America. Reported Earnings • Jul 26
Second quarter 2023 earnings released: EPS: Mex$1.00 (vs Mex$0.45 in 2Q 2022) Second quarter 2023 results: EPS: Mex$1.00 (up from Mex$0.45 in 2Q 2022). Revenue: Mex$3.33b (flat on 2Q 2022). Net income: Mex$547.5m (up 120% from 2Q 2022). Profit margin: 17% (up from 7.4% in 2Q 2022). Revenue is forecast to grow 10.0% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South America are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. New Risk • Jun 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Mexican stocks, typically moving 4.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (94% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (4.6% average weekly change). Reported Earnings • Apr 28
First quarter 2023 earnings released: EPS: Mex$0.85 (vs Mex$0.38 in 1Q 2022) First quarter 2023 results: EPS: Mex$0.85 (up from Mex$0.38 in 1Q 2022). Revenue: Mex$3.67b (up 20% from 1Q 2022). Net income: Mex$461.0m (up 116% from 1Q 2022). Profit margin: 13% (up from 7.0% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South America are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Upcoming Dividend • Apr 03
Upcoming dividend of Mex$0.46 per share at 2.1% yield Eligible shareholders must have bought the stock before 10 April 2023. Payment date: 12 April 2023. Payout ratio is a comfortable 19% but the company is paying out more than the cash it is generating. Trailing yield: 2.1%. Lower than top quartile of Mexican dividend payers (6.1%). Lower than average of industry peers (15%). Price Target Changed • Feb 27
Price target increased by 16% to Mex$42.90 Up from Mex$37.00, the current price target is an average from 3 analysts. New target price is 150% above last closing price of Mex$17.15. Stock is up 29% over the past year. The company posted earnings per share of Mex$2.23 last year. Reported Earnings • Feb 24
Full year 2022 earnings released: EPS: Mex$2.23 (vs Mex$1.00 in FY 2021) Full year 2022 results: EPS: Mex$2.23 (up from Mex$1.00 in FY 2021). Revenue: Mex$13.6b (up 20% from FY 2021). Net income: Mex$1.22b (up 119% from FY 2021). Profit margin: 9.0% (up from 4.9% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 2.0% decline forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 11% per year. Price Target Changed • Nov 16
Price target decreased to Mex$32.23 Down from Mex$37.00, the current price target is an average from 3 analysts. New target price is 148% above last closing price of Mex$13.00. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of Mex$1.30 for next year compared to Mex$1.00 last year. Reported Earnings • Oct 26
Third quarter 2022 earnings released: EPS: Mex$0.41 (vs Mex$0.19 in 3Q 2021) Third quarter 2022 results: EPS: Mex$0.41 (up from Mex$0.19 in 3Q 2021). Revenue: Mex$3.55b (up 26% from 3Q 2021). Net income: Mex$222.6m (up 101% from 3Q 2021). Profit margin: 6.3% (up from 4.0% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 1.8% decline forecast for the Chemicals industry in South America. Over the last 3 years on average, earnings per share has fallen by 17% per year whereas the company’s share price has fallen by 19% per year. Price Target Changed • Sep 30
Price target decreased to Mex$33.90 Down from Mex$37.00, the current price target is provided by 1 analyst. New target price is 161% above last closing price of Mex$13.00. Stock is down 7.5% over the past year. The company is forecast to post earnings per share of Mex$1.30 for next year compared to Mex$1.00 last year. Reported Earnings • Jul 27
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: Mex$3.36b (up 18% from 2Q 2021). Net income: Mex$248.0m (up Mex$215.9m from 2Q 2021). Profit margin: 7.4% (up from 1.1% in 2Q 2021). The increase in margin was driven by higher revenue. Reported Earnings • May 01
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: Mex$0.38 (up from Mex$0.13 in 1Q 2021). Revenue: Mex$3.06b (up 18% from 1Q 2021). Net income: Mex$213.4m (up 182% from 1Q 2021). Profit margin: 7.0% (up from 2.9% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates by 26%. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings. Price Target Changed • Apr 27
Price target decreased to Mex$33.77 Down from Mex$37.00, the current price target is provided by 1 analyst. New target price is 150% above last closing price of Mex$13.50. Stock is down 4.1% over the past year. The company is forecast to post earnings per share of Mex$1.50 for next year compared to Mex$1.00 last year. Reported Earnings • Feb 28
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: Mex$1.00 (up from Mex$0.92 in FY 2020). Revenue: Mex$11.3b (up 5.7% from FY 2020). Net income: Mex$557.0m (up 9.0% from FY 2020). Profit margin: 4.9% (up from 4.8% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 23%. Over the next year, revenue is forecast to grow 3.0%, compared to a 4.6% growth forecast for the industry in Mexico. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Jan 01
Investor sentiment improved over the past week After last week's 15% share price gain to Mex$14.93, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry globally. Total loss to shareholders of 50% over the past three years. Price Target Changed • Oct 30
Price target decreased to Mex$33.77 Down from Mex$37.00, the current price target is provided by 1 analyst. New target price is 145% above last closing price of Mex$13.80. Stock is down 34% over the past year. The company is forecast to post earnings per share of Mex$0.80 for next year compared to Mex$0.92 last year. Reported Earnings • Oct 29
Third quarter 2021 earnings released: EPS Mex$0.19 (vs Mex$0.11 loss in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: Mex$2.81b (down 1.7% from 3Q 2020). Net income: Mex$110.9m (up Mex$174.5m from 3Q 2020). Profit margin: 4.0% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 22% per year whereas the company’s share price has fallen by 24% per year. Upcoming Dividend • Mar 30
Upcoming dividend of Mex$0.36 per share Eligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 2.4%. Lower than top quartile of Mexican dividend payers (4.9%). Lower than average of industry peers (4.1%). Reported Earnings • Mar 28
Full year 2020 earnings released: EPS Mex$0.92 (vs Mex$2.24 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: Mex$10.7b (up 2.1% from FY 2019). Net income: Mex$511.0m (down 60% from FY 2019). Profit margin: 4.8% (down from 12% in FY 2019). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Feb 25
New 90-day low: Mex$17.40 The company is down 19% from its price of Mex$21.50 on 25 November 2020. The Mexican market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. Is New 90 Day High Low • Jan 26
New 90-day low: Mex$17.99 The company is down 14% from its price of Mex$21.00 on 26 October 2020. The Mexican market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period. Is New 90 Day High Low • Jan 11
New 90-day low: Mex$19.87 The company is down 1.0% from its price of Mex$20.00 on 13 October 2020. The Mexican market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period. Ankündigung • Sep 25
Bemis Company, Inc. (NYSE:BMS) together with its Mexican joint venture partner purchased certain flexible packaging assets of Masterpak S.A. de C.V., including a converting facility in Tultitlan, Mexico. from Cydsa, S.A. de C.V. Bemis Company, Inc. (NYSE:BMS) together with its Mexican joint venture partner, it has completed the purchase of certain flexible packaging assets of Masterpak S.A. de C.V., including a converting facility in Tultitlan, Mexico. from Cydsa, S.A. de C.V. Bemis owns 51 percent of the acquired business. Specific terms of the acquisition were not disclosed. Recently reported annual sales related to the assets to be acquired were approximately $35 million. Fredericks Michael & Co. acted as the financial advisor to Cydsa.
Bemis Company, Inc., completed the acquisition of Masterpak S.A. de C.V., on May 26, 2004.